Whitehawk Therapeutics CEO Sells $49,010 in Stock to Cover RSU Taxes
Whitehawk Therapeutics Chief Executive Officer David James Lennon sold 14,500 shares of common stock on April 9, 2026, for $3.38 per share, netting $49,010. The sale, disclosed on a Form 4 filing, was executed to meet tax withholding obligations tied to vesting restricted stock units. Separately, the company presented research showing elevated and …